Cargando…

Diabetic kidney disease: Its current trends and future therapeutic perspectives

Diabetic kidney disease.[Image: see text]

Detalles Bibliográficos
Autor principal:	Koya, Daisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	JDI Updates
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717829/ https://www.ncbi.nlm.nih.gov/pubmed/31361399 http://dx.doi.org/10.1111/jdi.13121

Ejemplares similares

One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Recent updates and future perspectives on gestational diabetes mellitus: An important public health challenge
por: Chu, Leo Check Hei, et al.
Publicado: (2021)

Recent evidence in the etiology and treatment for diabetic kidney disease
por: Shikata, Kenichi
Publicado: (2020)

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
por: Matsuzaka, Takashi, et al.
Publicado: (2020)

A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis
por: Hotta, Nigishi
Publicado: (2019)

Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia
por: Seino, Yusuke, et al.
Publicado: (2019)

Cardiovascular disease in patients with type 2 diabetes
por: Jeon, Ja Young, et al.
Publicado: (2022)

New perspectives on insulin therapy
por: Araki, Eiichi, et al.
Publicado: (2020)

In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
por: Lee, Chi‐Ho, et al.
Publicado: (2020)

The journey to understanding incretin systems: Theory, practice and more theory
por: Yabe, Daisuke, et al.
Publicado: (2019)

Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
por: Lin, Kuan‐Yu, et al.
Publicado: (2021)

Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
por: Nakamura, Toshihiro, et al.
Publicado: (2020)

Updates in diabetic neuropathy: A call for new diagnostic and treatment approaches
por: Aso, Yoshimasa
Publicado: (2021)

New prospects for incretin‐related drugs in the treatment of type 2 diabetes
por: Kimura, Tomohiko, et al.
Publicado: (2020)

Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
por: Himeno, Tatsuhito, et al.
Publicado: (2019)

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020)

Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
por: Fujita, Yoshihito, et al.
Publicado: (2019)

SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use
por: Hosokawa, Yusei, et al.
Publicado: (2020)

Clinical evidence regarding factors linking metabolic abnormal obesity to pancreatic β‐cell dysfunction
por: Watada, Hirotaka
Publicado: (2020)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
por: Kawamori, Dan
Publicado: (2020)

Obesity, metabolic syndrome and bariatric surgery: A narrative review
por: Jia, Weiping
Publicado: (2020)

Blood glucose control: Where are we?
por: Lee, Moon‐Kyu
Publicado: (2021)

Impaired insulin secretion and related factors in East Asian individuals
por: Nakamura, Akinobu, et al.
Publicado: (2021)

Current status of diabetic kidney disease and latest trends in management
por: Kim, Min Kyung, et al.
Publicado: (2022)

A new era of diabetic kidney disease treatment with sodium–glucose cotransporter‐2 inhibitors
por: Kume, Shinji, et al.
Publicado: (2022)

Effectiveness of the Shenzhuo formula in the treatment of patients with macroalbuminuria secondary to diabetic kidney disease: protocol update and statistical analysis plan
por: Wei, Yu, et al.
Publicado: (2022)

Telemedicine in Diabetic Retinopathy: Current Status and Future Directions
por: Das, Taraprasad, et al.
Publicado: (2015)

An update on migraine: current understanding and future directions
por: Puledda, Francesca, et al.
Publicado: (2017)

The era of continuous glucose monitoring and its expanded role in type 2 diabetes
por: Yu, Jin, et al.
Publicado: (2023)

Therapeutic management of diabetic kidney disease
por: Koya, Daisuke, et al.
Publicado: (2011)

Dual protein kinase C alpha and beta inhibitors and diabetic kidney disease: a revisited therapeutic target for future clinical trials
por: Koya, Daisuke
Publicado: (2013)

Medicare Home Health Initative: Current Activities and Future Directions
por: Mauser, Elizabeth
Publicado: (1997)

Freeze-all cycle in reproductive medicine: current perspectives
por: Roque, Matheus, et al.
Publicado: (2017)

Recent updates in factors associated with incidence and screening of diabetic eye disease
por: Sone, Hirohito
Publicado: (2023)

New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson’s disease
por: Keir, Lindsay H. M., et al.
Publicado: (2019)

BENIGN BONE TUMORS AND TUMOR-LIKE BONE LESIONS: TREATMENT UPDATE AND NEW TRENDS
por: Nogueira Drumond, José Marcos
Publicado: (2015)

No wisdom in the crowd: genome annotation in the era of big data – current status and future prospects
por: Danchin, Antoine, et al.
Publicado: (2018)

Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions
por: Varley, James, et al.
Publicado: (2014)

Sarcopenia in elderly diabetes
por: Wen, Chen‐Yu, et al.
Publicado: (2022)

NAVKIDS(2) trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease — statistical analysis plan and update to the protocol
por: van Zwieten, Anita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_90qc7rksg0r98p65nucotgvubb